Co-Diagnostics Inc (NASDAQ:CODX)
| 4.55 Delayed Data As of May 13 |  +0.59 / +14.90%Today’s Change | 3.66 Today|||52-Week Range 11.82 | -49.05% Year-to-Date |
Latest CODX News | Press Releases
| CoDiagnostics, Inc. (CODX) Q1 Earnings and Revenues Beat Estimates May 12 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 3.96 |
| Today’s open | 4.13 |
| Day’s range | 4.12 - 4.64 |
| Volume | 414,948 |
| Average volume (3 months) | 431,221 |
| Market cap | $155.3M |
Data as of 4:00pm ET, 05/13/2022
Growth & Valuation
| Earnings growth (last year) | -20.14% |
| Earnings growth (this year) | -46.88% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +31.30% |
| P/E ratio | 3.7 |
| Price/Sales | 2.73 |
| Price/Book | 1.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATHXAthersys Inc | +0.03 | +5.33% |
| MXDHFMDxHealth SA | 0.00 | 0.00% |
| RYTMRhythm Pharmaceutica... | -0.20 | -5.81% |
| ALDXAldeyra Therapeutics... | +0.06 | +2.47% |
Data as of 4:06pm ET, 05/13/2022
Financials
| Next reporting date | August 18, 2022 |
| EPS forecast (this quarter) | $0.12 |
| Annual revenue (last year) | $97.9M |
| Annual profit (last year) | $36.7M |
| Net profit margin | 37.45% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
